Colleen M Craig

Title: The Innovative Contributions of Colleen M. Craig

Introduction

Colleen M. Craig is a renowned inventor based in Stanford, CA, who has made significant strides in medical innovation, particularly in the treatment of hyperinsulinemic hypoglycemia. With an impressive portfolio of 10 patents, Craig's work is at the forefront of improving patient outcomes in this critical area.

Latest Patents

One of Colleen M. Craig's latest patents, titled "Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)," outlines a method involving the administration of an effective amount of a glucagon-like peptide-1 receptor antagonist (GLP1RA) alone or in combination with other agents. This innovative treatment addresses the urgent need for a remedy for patients suffering from hyperinsulinemic hypoglycemia following bariatric surgery, who benefit significantly from this approach. The patent emphasizes the potential to prevent or reduce acute adverse effects such as palpitations, tremor, and confusion, as well as chronic complications including cognitive impairment.

Another remarkable patent by Craig is "Treatment of post-bariatric hypoglycemia with exendin (9-39)," which presents compositions and methods for treating hyperinsulinemic hypoglycemia in patients post-bariatric surgery. This invention details the subcutaneous administration of exendin(9-39) twice daily as a strategy for effective treatment, marking a critical advancement in medical therapeutics.

Career Highlights

Colleen M. Craig has been affiliated with prestigious institutions, including Leland Stanford Junior University, where she harnessed her expertise in the field to contribute to significant advancements in medical science. Her extensive research and innovative creations have positioned her as a leader within the medical community.

Collaborations

Throughout her career, Craig has collaborated with esteemed professionals such as Tracey L. McLaughlin and Xiaofeng Xiong. These partnerships have been pivotal in advancing her research and in the successful development of her patented technologies.

Conclusion

Colleen M. Craig's contributions to the field of medical innovation through her patents have opened new avenues for the treatment of hyperinsulinemic hypoglycemia, especially for patients undergoing bariatric surgery. Her dedication to improving patient care through innovative research and collaboration underscores her role as a remarkable inventor in the medical field.